Menu Back toV7-S4

14th DIA Japan Annual Meeting 2017

[V7-S4] More Advanced Approach of Medical Big Data - Part 1

    Session Chair(s)
      Hisashi  Urushihara, DrPH, MS

      Hisashi Urushihara, DrPH, MS

      • Professor, Div. of Drug Development and Regulatory Science, Faculty of Pharmacy
      • Keio University, Japan
      Yuji  Yamamoto, MD, MBA

      Yuji Yamamoto, MD, MBA

      • Founder and CEO
      • MinaCare Co., Ltd., Japan
    Medical big data have become indispensable in medicine development. Many people have been making decision by reference to information come from big data analysis. In this session, we will comprehensively review the advanced approach for big data utilization and future perspective with pioneering experts from Global as well as Japan. We will share advanced examples of clinical trial design and operations including randomized pragmatic trials, outcomes research and post-marketing safety assessments. The potential impact of GCP renovation will also be discussed.
      Nancy  Dreyer, DIAFellow, PhD, MPH, FISPE

      Real-World Evidence and Next Generation Regulatory Decision Making

      Nancy Dreyer, DIAFellow, PhD, MPH, FISPE

      • Global Chief, Sci Affairs; Sr VP, Head, Center for Advanced Evidence Generation
      • IQVIA, United States
      Akiyuki  Suzuki, MS

      Application of Medical Big Data to Clinical Trial Simulation

      Akiyuki Suzuki, MS

      • Senior Manager, Pharmacometrics Group, Clinical Pharmacology
      • Pfizer Japan Inc., Japan
      Shinzo  Hiroi, PhD, MPH, RPh, PMP

      Application Case-Outcomes Research using Real World Data -

      Shinzo Hiroi, PhD, MPH, RPh, PMP

      • Head of Global Medical Affairs, Global Medical Affairs
      • Shionogi & Co., Ltd., Japan

Contact us

Please contact the DIA Japan office in Tokyo for further information.

Tel: +81-3-6214-0574
Fax: +81-3-3278-1313